Search images on Google Product Monograph
Active Ingredients:
- bismuth dipropylacetate, 135 MG
DIN: 00065927
Dosage Form(s): SUPPOSITORY
Route(s) of Administration: RECTAL
Schedule: OTC
Company: TEVA CANADA LIMITED – official site
ATC:
- R02 - THROAT PREPARATIONS (ATC, WHO, Wiki)
- R02A - THROAT PREPARATIONS (ATC, WHO)
- R02AA - Antiseptics (ATC, WHO)
- R02AA20 - VARIOUS (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 135MG
Pharmaceutical standard: MFR
External Links for Neo-Laryngobis:
Search on Google
- Neo-Laryngobis side effects
- Neo-Laryngobis dosage
- bismuth dipropylacetate side effects
- bismuth dipropylacetate dosage
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find neo-laryngobis photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.